Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Pandini

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Oncogene|November 26, 2002
In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform ALaura Sciacca, Rossana Mineo, Giuseppe Pandini, et al.
Annals of the New York Academy of Sciences|January 15, 2005
IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin bindingGiuseppe Pandini, Enrico Conte, Enzo Medico, et al.
Cancer Research|September 19, 2007
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cellsGiuseppe Pandini, Marco Genua, Francesco Frasca, et al.
The Journal of Biological Chemistry|July 26, 2002
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involvedGiuseppe Pandini, Francesco Frasca, Rossana Mineo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2007
Functional responses and in vivo anti-tumour activity of h7C10: a humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptorsGiuseppe Pandini, Thierry Wurch, Barbara Akla, et al.
Frontiers in Endocrinology|May 6, 2021
Thyroid Stem Cells But Not Differentiated Thyrocytes Are Sensitive to Slightly Increased Concentrations of Heavy MetalsFiorenza Gianì, Roberta Masto, Maria Antonietta Trovato, et al.
Molecular Cancer Research : MCR|February 1, 2008
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradationRoberta Malaguarnera, Veronica Vella, Giuseppe Pandini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2010
HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor geneAurora Aiello, Giuseppe Pandini, Rive Sarfstein, et al.
Archives of Physiology and Biochemistry|May 10, 2008
The role of insulin receptors and IGF-I receptors in cancer and other diseasesFrancesco Frasca, Giuseppe Pandini, Laura Sciacca, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancerVeronica Vella, Giuseppe Pandini, Laura Sciacca, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Oncogene|November 26, 2002
In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform ALaura Sciacca, Rossana Mineo, Giuseppe Pandini, et al.
Annals of the New York Academy of Sciences|January 15, 2005
IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin bindingGiuseppe Pandini, Enrico Conte, Enzo Medico, et al.
Cancer Research|September 19, 2007
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cellsGiuseppe Pandini, Marco Genua, Francesco Frasca, et al.
The Journal of Biological Chemistry|July 26, 2002
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involvedGiuseppe Pandini, Francesco Frasca, Rossana Mineo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2007
Functional responses and in vivo anti-tumour activity of h7C10: a humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptorsGiuseppe Pandini, Thierry Wurch, Barbara Akla, et al.
Frontiers in Endocrinology|May 6, 2021
Thyroid Stem Cells But Not Differentiated Thyrocytes Are Sensitive to Slightly Increased Concentrations of Heavy MetalsFiorenza Gianì, Roberta Masto, Maria Antonietta Trovato, et al.
Molecular Cancer Research : MCR|February 1, 2008
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradationRoberta Malaguarnera, Veronica Vella, Giuseppe Pandini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2010
HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor geneAurora Aiello, Giuseppe Pandini, Rive Sarfstein, et al.
Archives of Physiology and Biochemistry|May 10, 2008
The role of insulin receptors and IGF-I receptors in cancer and other diseasesFrancesco Frasca, Giuseppe Pandini, Laura Sciacca, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancerVeronica Vella, Giuseppe Pandini, Laura Sciacca, et al.
Pageof 4